137 related articles for article (PubMed ID: 38237687)
1. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors - Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.
Nittayacharn P; Abenojar E; Cooley MB; Berg FM; Counil C; Sojahrood AJ; Khan MS; Yang C; Berndl E; Golczak M; Kolios MC; Exner AA
J Control Release; 2024 Mar; 367():135-147. PubMed ID: 38237687
[TBL] [Abstract][Full Text] [Related]
2. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors - Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.
Nittayacharn P; Abenojar E; Cooley M; Berg F; Counil C; Sojahrood AJ; Khan MS; Yang C; Berndl E; Golczak M; Kolios MC; Exner AA
bioRxiv; 2023 Sep; ():. PubMed ID: 37732235
[TBL] [Abstract][Full Text] [Related]
3. Increasing Doxorubicin Loading in Lipid-Shelled Perfluoropropane Nanobubbles
Nittayacharn P; Abenojar E; De Leon A; Wegierak D; Exner AA
Front Pharmacol; 2020; 11():644. PubMed ID: 32477125
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles.
Nittayacharn P; Yuan HX; Hernandez C; Bielecki P; Zhou H; Exner AA
J Pharm Sci; 2019 Sep; 108(9):3091-3098. PubMed ID: 31095958
[TBL] [Abstract][Full Text] [Related]
5. Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake
Bellary A; Villarreal A; Eslami R; Undseth QJ; Lec B; Defnet AM; Bagrodia N; Kandel JJ; Borden MA; Shaikh S; Chopra R; Laetsch TW; Delaney LJ; Shaw CM; Eisenbrey JR; Hernandez SL; Sirsi SR
Theranostics; 2020; 10(18):8143-8161. PubMed ID: 32724463
[TBL] [Abstract][Full Text] [Related]
6. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy.
Thomas E; Menon JU; Owen J; Skaripa-Koukelli I; Wallington S; Gray M; Mannaris C; Kersemans V; Allen D; Kinchesh P; Smart S; Carlisle R; Vallis KA
Theranostics; 2019; 9(19):5595-5609. PubMed ID: 31534505
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-mediated drug-free theranostics for treatment of prostate cancer.
Perera RH; Berg FM; Abenojar EC; Nittayacharn P; Kim Y; Wang X; Basilion JP; Exner AA
bioRxiv; 2023 Sep; ():. PubMed ID: 37745586
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction.
Fan X; Wang L; Guo Y; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3585-96. PubMed ID: 27536100
[TBL] [Abstract][Full Text] [Related]
10. Effects of encapsulated gas on stability of lipid-based microbubbles and ultrasound-triggered drug delivery.
Omata D; Maruyama T; Unga J; Hagiwara F; Munakata L; Kageyama S; Shima T; Suzuki Y; Maruyama K; Suzuki R
J Control Release; 2019 Oct; 311-312():65-73. PubMed ID: 31461665
[TBL] [Abstract][Full Text] [Related]
11. The relationship between surface drug distribution of Dox-loaded microbubbles and drug release/cavitation behaviors with ultrasound.
Lin CW; Fan CH; Yeh CK
Ultrason Sonochem; 2024 Jan; 102():106728. PubMed ID: 38103369
[TBL] [Abstract][Full Text] [Related]
12. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery.
Fan CH; Ting CY; Lin HJ; Wang CH; Liu HL; Yen TC; Yeh CK
Biomaterials; 2013 May; 34(14):3706-15. PubMed ID: 23433776
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues.
Ingram N; McVeigh LE; Abou-Saleh RH; Maynard J; Peyman SA; McLaughlan JR; Fairclough M; Marston G; Valleley EMA; Jimenez-Macias JL; Charalambous A; Townley W; Haddrick M; Wierzbicki A; Wright A; Volpato M; Simpson PB; Treanor DE; Thomson NH; Loadman PM; Bushby RJ; Johnson BRG; Jones PF; Evans JA; Freear S; Markham AF; Evans SD; Coletta PL
Theranostics; 2020; 10(24):10973-10992. PubMed ID: 33042265
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
[TBL] [Abstract][Full Text] [Related]
15. Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging.
Liao AH; Li YK; Lee WJ; Wu MF; Liu HL; Kuo ML
Ultrasound Med Biol; 2012 Nov; 38(11):1938-48. PubMed ID: 22929655
[TBL] [Abstract][Full Text] [Related]
16. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
Chen Y; Liang Y; Jiang P; Li F; Yu B; Yan F
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41842-41852. PubMed ID: 31633326
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Two Approaches for the Attachment of a Drug to Gold Nanoparticles and Their Anticancer Activities.
Fu Y; Feng Q; Chen Y; Shen Y; Su Q; Zhang Y; Zhou X; Cheng Y
Mol Pharm; 2016 Sep; 13(9):3308-17. PubMed ID: 27518201
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery.
Escoffre JM; Mannaris C; Geers B; Novell A; Lentacker I; Averkiou M; Bouakaz A
IEEE Trans Ultrason Ferroelectr Freq Control; 2013 Jan; 60(1):78-87. PubMed ID: 23287915
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.
Kim D; Lee JH; Moon H; Seo M; Han H; Yoo H; Seo H; Lee J; Hong S; Kim P; Lee HJ; Chung JW; Kim H
Theranostics; 2021; 11(1):79-92. PubMed ID: 33391462
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-mediated drug-free theranostics for treatment of prostate cancer.
Perera RH; Berg FM; Abenojar EC; Nittayacharn P; Kim Y; Wang X; Basilion JP; Exner A
Bioact Mater; 2024 May; 35():45-55. PubMed ID: 38304914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]